Avalo Therapeutics AVTX Pennsylvania — Operating lease, expense

Similar metrics at other companies

MURCanada — Operating Lease, Expense

$44.9M-4.7%

MURUnited States — Operating Lease, Expense

$97.8M-37.9%

SGRYLease expense

$23M+10.6%

ALLOOperating Lease Expense

$1.07M-5.4%

VOROperating Lease Expense

$109K-91.7%

VKTXCA — Operating Lease Expense

$63K—

Questions, answered.

What is Avalo Therapeutics's pennsylvania — operating lease, expense?

Avalo Therapeutics (AVTX) reported pennsylvania — operating lease, expense of $100K in Q1 2026.

How has Avalo Therapeutics's pennsylvania — operating lease, expense changed year-over-year?

Avalo Therapeutics's pennsylvania — operating lease, expense decreased by 0.0% year-over-year, from $100K to $100K.

What does pennsylvania — operating lease, expense mean?

This metric captures the total recognized operating lease expense for assets situated in the Pennsylvania region, typically calculated on a straight-line basis over the lease term. It serves as a key indicator of the periodic cost of occupying facilities necessary for clinical or administrative operations. Tracking this expense provides insight into the operational cost structure and the impact of regional leasing activities on the income statement.